TrialJournal of cancer research and clinical oncology2022

Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial.

Osman Öcal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.